BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2688103)

  • 1. Biochemistry and genetic engineering of hirudin.
    Johnson PH; Sze P; Winant R; Payne PW; Lazar JB
    Semin Thromb Hemost; 1989 Jul; 15(3):302-15. PubMed ID: 2688103
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant hirudin: genetic engineering and structure analysis.
    Märki WE; Grossenbacher H; Grütter MG; Liersch MH; Meyhack B; Heim J
    Semin Thromb Hemost; 1991 Apr; 17(2):88-93. PubMed ID: 1771417
    [No Abstract]   [Full Text] [Related]  

  • 3. CX-397, a novel recombinant hirudin analog having a hybrid sequence of hirudin variants-1 and -3.
    Komatsu Y; Misawa S; Sukesada A; Ohba Y; Hayashi H
    Biochem Biophys Res Commun; 1993 Oct; 196(2):773-9. PubMed ID: 8240353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent developments in the biochemistry of hirudins].
    Walsmann P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):821-30. PubMed ID: 2483699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and evaluation of recombinant hirudin.
    Courtney M; Loison G; Lemoine Y; Riehl-Bellon N; Degryse E; Brown SW; Cazenave JP; Defreyn G; Delebassee D; Bernat A
    Semin Thromb Hemost; 1989 Jul; 15(3):288-92. PubMed ID: 2688101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of recombinant hirudins.
    Stürzebecher J; Walsmann P
    Semin Thromb Hemost; 1991 Apr; 17(2):94-8. PubMed ID: 1771418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immobilized hirudin and hirudin-based peptides used for the purification of recombinant human thrombin prepared from recombinant human prothrombin.
    Fischer BE; Mitterer A; Schlokat U; Grillberger L; Reiter M; Mundt W; Dorner F; Eibl J
    Protein Expr Purif; 1996 Sep; 8(2):167-74. PubMed ID: 8812854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the distance between the two binding sites of hirudin for its interaction with the active site and the fibrin(ogen)-binding site of alpha-thrombin.
    Wagner U; Schmitz T; Otte M; Dodt J
    Biomed Biochim Acta; 1991; 50(4-6):707-10. PubMed ID: 1801747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin interactions with hirudin.
    Fenton JW
    Semin Thromb Hemost; 1989 Jul; 15(3):265-8. PubMed ID: 2688098
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimization of expression of an annexin V-hirudin chimeric protein in Escherichia coli.
    Yuan H; Yang X; Hua ZC
    Microbiol Res; 2004; 159(2):147-56. PubMed ID: 15293949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of site specific amino acid exchanges in hirudin on the thrombin-hirudin interaction.
    Köhler S; Dodt J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):24-9. PubMed ID: 2459027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and characterization of a novel staphylokinase variant with thrombin-inhibitory activity.
    Wang M; Wang Y; Wang J; Zou M; Liu S; Xu T; Cai X; Wu C; Wang J; Xu D
    Biotechnol Lett; 2009 Dec; 31(12):1923-7. PubMed ID: 19685208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of recombinant hirudin.
    Nowak G
    Semin Thromb Hemost; 2002 Oct; 28(5):415-24. PubMed ID: 12420236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hirudin and hirudin-based peptides.
    Stone SR; Maraganore JM
    Methods Enzymol; 1993; 223():312-36. PubMed ID: 8271960
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel method of expression and purification of hirudin based on pBAD TOPO, pTYB12 vectors and gene synthesis.
    Kochanowski R; Kotłowski R; Szweda P
    Protein Expr Purif; 2006 Nov; 50(1):25-30. PubMed ID: 16857385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant expression of selectively sulfated proteins in Escherichia coli.
    Liu CC; Schultz PG
    Nat Biotechnol; 2006 Nov; 24(11):1436-40. PubMed ID: 17072302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biochemical and pharmacological aspects of the thrombin inhibitor hirudin].
    Walsmann P; Markwardt F
    Pharmazie; 1981 Oct; 36(10):653-60. PubMed ID: 7031705
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of hirudin as an antithrombotic agent.
    Markwardt F
    Semin Thromb Hemost; 1989 Jul; 15(3):269-82. PubMed ID: 2688099
    [No Abstract]   [Full Text] [Related]  

  • 19. The comeback of hirudin--an old-established anticoagulant agent.
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):10-23. PubMed ID: 2459000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulphation of hirudin in BHK cells.
    Skern T; Bischoff R; Jallat S; Dott K; Ali-Hadji D; Clesse D; Kieny MP; Courtney M
    FEBS Lett; 1990 Nov; 275(1-2):36-8. PubMed ID: 2261997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.